The Food Effect on PK Characteristics and Safety Profiles of PA-111

Launched by ADDPHARMA INC. · May 9, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new medication called PA-111, which is being studied to understand how it behaves in the body and its safety when taken with food. The main goal is to see how the body processes this drug in healthy adults, which can provide important information about how it might work for people with mixed dyslipidemia, a condition related to unhealthy cholesterol levels.

To be eligible for this study, participants need to be at least 19 years old, weigh at least 50 kg (or 45 kg for females), and have a body mass index (BMI) between 18 and 30. They should also not have participated in any other clinical trials with investigational drugs in the past six months. If someone joins the study, they can expect to undergo screening and monitoring to ensure their safety while taking the medication. It's important to note that this trial is not yet recruiting participants, so there will be more updates to come for those interested in taking part.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
• • The Age equal to or greater than 19 in healthy volunteers at the time of screening visit
• Exclusion Criteria:
• • Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
• • Other exclusions applied